Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry
-
Published:2024-01-16
Issue:
Volume:
Page:
-
ISSN:1179-1985
-
Container-title:High Blood Pressure & Cardiovascular Prevention
-
language:en
-
Short-container-title:High Blood Press Cardiovasc Prev
Author:
Parra Ramírez Paola, Martín Rojas-Marcos Patricia, Paja Fano Miguel, González-Boillos Margarita, Pascual-Corrales Eider, García Cano Ana María, Ruiz-Sanchez Jorge Gabriel, Vicente Delgado Almudena, Gómez Hoyos Emilia, Ferreira Rui, García Sanz Iñigo, Recasens Sala Mònica, Barahona San Millan Rebeca, Picón César María José, Díaz Guardiola Patricia, Perdomo Carolina M., Manjón-Miguélez Laura, Rebollo Román Ángel, Robles Lázaro Cristina, Morales-Ruiz Manuel, Calatayud María, Andree Furio Collao Simone, Meneses Diego, Sampedro-Nuñez Miguel Antonio, Mena Ribas Elena, Sanmartín Sánchez Alicia, Gonzalvo Diaz Cesar, Lamas Cristina, Guerrero-Vázquez Raquel, del Castillo Tous María, Serrano Gotarredona Joaquín, Michalopoulou Alevras Theodora, Tenés Rodrigo Susana, Roa Chamorro Ricardo, Jaen Aguila Fernando, Moya Mateo Eva María, Hanzu Felicia A., Araujo-Castro MartaORCID
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Internal Medicine
Reference25 articles.
1. Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41–50. https://doi.org/10.1016/S2213-8587(17)30319-4. (Epub 2017 Nov 9 PMID: 29129575). 2. Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F, Veglio F. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98(12):4826–33. https://doi.org/10.1210/jc.2013-2805. (Epub 2013 Sep 20 PMID: 24057288). 3. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916. https://doi.org/10.1210/jc.2015-4061. (Epub 2016 Mar 2 PMID: 26934393). 4. Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism. JAMA Cardiol. 2018;3:768–74. https://doi.org/10.1001/jamacardio.2018.2003. 5. Köhler A, Sarkis AL, Heinrich DA, Müller L, Handgriff L, Deniz S, Schneider H, Künzel H, Ladurner R, Reincke M, Adolf C. Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study. Eur J Endocrinol. 2021;185(5):663–72. https://doi.org/10.1530/EJE-21-0018. (PMID: 34468397).
|
|